Bromo-PEG2-azide | 530151-56-5
Catalog Number | R14-0184 |
Category | Azides |
Molecular Formula | C6H12BrN3O2 |
Molecular Weight | 238.08 |
Catalog Number | Size | Price | Quantity |
---|---|---|---|
R14-0184 | -- | $-- |
- Worldwide Delivery
- Quality Assurance
- 24/7 Customer Service
Product Introduction
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Chemical Information |
|
---|---|
Synonyms | 1-(2-azidoethoxy)-2-(2-bromoethoxy)ethane; Br-PEG2-N3; N3-PEG2-CH2CH2Br; Bromo-PEG2-C2-azide; Ethane, 1-(2-azidoethoxy)-2-(2-bromoethoxy)-; Azido-PEG2-Br |
Purity | ≥95% |
IUPAC Name | 1-azido-2-[2-(2-bromoethoxy)ethoxy]ethane |
Canonical SMILES | C(COCCOCCBr)N=[N+]=[N-] |
InChI | InChI=1S/C6H12BrN3O2/c7-1-3-11-5-6-12-4-2-9-10-8/h1-6H2 |
InChI Key | QZCKRLVDTQCBFT-UHFFFAOYSA-N |
Solubility | Soluble in DCM, DMF, DMSO |
Appearance | Pale Yellow or Colorless Oily Matter |
LogP | 0.82 |
- Product Specification
Storage | Store at 2-8°C |
Computed Properties | |
---|---|
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 237.01129 g/mol |
Monoisotopic Mass | 237.01129 g/mol |
Topological Polar Surface Area | 32.8Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 139 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
Patents
Publication Number | Title | Priority Date |
---|---|---|
KR-20220142393-A | Protein degrader conjugate and the use thereof | 2021-04-14 |
WO-2022220625-A1 | Protein degrader conjugates and use thereof | 2021-04-14 |
WO-2021111185-A1 | Compositions and methods related to molecular conjugation | 2019-12-02 |
WO-2020146521-A2 | Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use | 2019-01-09 |
TW-202043470-A | Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use | 2019-01-09 |
Applications of Fluorescent Probes & Dyes
Get More Product Details?
Related Products